Multiple Sclerosis and Related Disorders

Latest articles

• Feasibility and efficacy of peak-velocity interval training vs. moderate-intensity walking training in people with multiple sclerosis with severe fatigue and walking impairment: A pilot randomized controlled trial.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case series.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• A practical guide for rapid disease modifying therapy initiation and maintenance in aquaporin-4 positive neuromyelitis optica.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Baseline predictors of sustained fatigue onset in multiple sclerosis: A longitudinal survival analysis of the MS PATHS cohort.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Ramadan fasting in multiple sclerosis: A systematic review.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Efficacy of a fixed-interval, body surface area-adjusted rituximab regimen in Singaporean patients with CNS inflammatory demyelinating diseases.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Timothy K. Vartanian (1959-2025) pioneering neuroscientist who traced multiple sclerosis to a microbial source.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The Chinese (Cantonese) brief international cognitive assessment for multiple sclerosis (BICAMS): A validation study in Hong Kong.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• MRI in detection of acute optic neuritis: A systematic review and meta-analysis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Neurocognitive outcomes in older adults with multiple sclerosis: Evidence from a cross-sectional cohort.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Influence of FCGR2A (rs1801274) and FCGR3A (rs396991) polymorphisms on natalizumab response on multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Usage and limitations of neuroglial biomarkers NfL and GFAP in urine as non-invasive disease markers in multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Nutritional status and taste impairment in adult patients with multiple sclerosis and dysphagia. A pilot study.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Towards practical management of the Marburg variant of multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The association between objective measures of sleep and physical activity in individuals with multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Brain Age.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Significance and stability of cerebrospinal fluid oligoclonal band patterns in multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The impact of COVID-19 on medical care and health service access in persons with multiple sclerosis - a cross-sectional study from the Australian MS Longitudinal Study.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Hypogammaglobulinemia and infection risks in multiple sclerosis patients receiving anti-CD20 monoclonal antibodies: Incidence, clinical implications, and longitudinal insights from a three-year Iranian cohort.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Solar rays incidence on the prevalence of multiple sclerosis and its correlation with Brazil's macroregions: A systematic review and metanalysis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Cognitive impairment and multiparametric brain MRI in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Adherence to the MIND diet and onset of neuromyelitis optica spectrum disorder: A case-control study.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Comment on "Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis".

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Perceived pain during isometric exercise and neuromuscular fatigability in individuals with multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Dynamics of plasma fibrinogen unveils hepatic initiating role in the pathogenesis of multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Development of a machine learning model to predict the expanded disability status scale in multiple sclerosis patients.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The brainstem signature of multiple sclerosis: predictable lesions, consistent syndromes.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Transfer of interferon beta in term placentae.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The association between antimicrobial exposure and subsequent multiple sclerosis risk: A systematic review and meta-analysis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• The effects of trunk rehabilitation on balance, gait, falls, and community mobility in patients with multiple sclerosis: A single-blind randomized controlled trial.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Investigating the causality and pathogenesis of multiple sclerosis in breast cancer via bioinformatics analysis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Discriminative ability of the six-minute walk distance in identifying fallers in multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Relapse activity during pregnancy and the postpartum year is associated with accelerated disability progression in multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Cognitive performances in people with neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Healthy lifestyle is associated with reduced fatigue, depression, and disability over 5 years in people with multiple sclerosis.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Effectiveness of rituximab in the treatment of multiple sclerosis: A multicenter, retrospective, observational study in morocco.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Auditory test of processing speed: Further validation and test-retest reliability.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• "Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center".

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Experience of bortezomib use in refractory autoimmune neurological disorders.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Transverse myelitis following COVID-19 infection or vaccination: Clinical outcomes and imaging characteristics compared with idiopathic cases.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Psychological resilience as a mediator between depression and health-related quality of life in relapsing-remitting multiple sclerosis patients.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurology.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Digital psychosocial tools and interventions for supporting informal caregivers of people with multiple sclerosis: a systematic review.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Outcomes of autologous stem cell transplantation in patients with multiple sclerosis: A United Arab Emirates experience.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025
• Is there a role of MOG antibodies in idiopathic intracranial hypertension: A comparative analysis with optic neuritis-MOG antibody associated disease.

  Sign in to saveExpandSign in for AI
  Multiple Sclerosis and Related Disorders · 2025